Sentinel Network meeting update
This article was originally published in The Tan Sheet
Executive Summary
FDA announces Feb. 15 it extended the registration deadline for a public meeting on the "Sentinel Network" to Feb. 28. FDA announced in January it scheduled a public meeting March 7 and 8 to discuss creating a private and public sector post-market network the agency says will integrate efforts to collect, analyze and disseminate product safety information to health care providers and patients (1"The Tan Sheet," Jan. 22, 2007, In Brief)...
You may also be interested in...
FDA public meeting
FDA will hold a public meeting to discuss the creation of a private and public sector post-market safety network titled "Sentinel Network," the agency announces in the Jan. 18 Federal Register. The meeting, which will be held March 7 and 8, will identify the "obstacles to facilitators and incentives for developing the data collection and risk identification and analysis components." FDA says "such a network would integrate existing and planned efforts to collect, analyze and disseminate medical product safety information to health care practitioners and patients at the point-of-care." FDA announced a similar online initiative in February 2006 for a second generation Adverse Event Reporting System (1"The Tan Sheet," Feb. 20, 2006, p. 5)...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.